Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Wells Fargo Healthcare Conference Transcript

Sep 04, 2019 / 12:30PM GMT
Release Date Price: $126.59 (-0.26%)
David William Maris
Wells Fargo Securities, LLC, Research Division - Former MD & Senior Analyst

Good morning, everyone. I am David Maris, Specialty Pharmaceuticals Analyst for Wells Fargo Securities. Welcome to our Healthcare Conference and for kicking it off this morning. Today, we have the management team from Jazz Pharmaceuticals with us. Dan Swisher, the President and Chief Operating Officer; and Katherine Littrell, the Vice President of Investor Relations is joining us.

This is the fireside chat. So you saw, and we can put it up again if you have any questions that you want to text. There will also be a microphone and you can wave your arms. I have a bunch of questions as well, and so I'll be joining the company management on the -- in the fireside chat without our fire, but to kick off in just a second.

But I do want to thank everyone for their attendance at our healthcare conference. The last time I was in Boston, I was hitting from home plate at Fenway Park for a charity event here. And so -- and I got to meet my childhood hero, Carl Yastrzemski. So Boston and I have a fond

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot